UK Markets close in 3 hrs 54 mins

Baxter International Inc. (0QK8.L)

LSE - LSE Delayed price. Currency in USD
Add to watchlist
84.87-0.30 (-0.35%)
As of 04:00PM GMT. Market open.
Sign in to post a message.
  • A
    Anonymous
    5-star analyst Danielle Antalffy, of SVB Leerink, writes of Baxter, “[We] see BAX's underlying fundamentals -- accelerating sales growth, meaningful margin expansion -- as unchanged. One of the most meaningful datapoints in this quarter was 6% peritoneal dialysis patient growth… well ahead of the mid-single-digit long-term growth outlook for the Renal business that the Street is modeling. As the COVID pressures begin to lift, visibility into the long-term growth drivers should improve, and we would expect the shares to move meaningfully higher.”

    And it doesn't hurt that Ray Dalio co-chief investment officer of the world's largest hedge fund, Bridgewater Associates just bought up 124,701 shares of the stock, a holding that is worth $9.73 million at current prices.
  • D
    Derrick
    2021 will be a great year for this company and due for a breakout given the strong fundamentals and an aging population.
  • D
    Daniel
    Holding on to BAX even though they have some accounting issues. Ultimately recoverable, I believe.
  • C
    Cassius King
    Maybe if they started making batteries and losing money, the stock would skyrocket?
  • T
    TC
    I wonder what the investors who were unloading BAX today know that I don't? True, it's not terribly unusual to see a stock go down despite a solid earnings report; but it is VERY unusual to see that stock drop nearly 10% to a new 52-week low on huge volume.
  • C
    Cat
    REUTERS: Baxter International Inc. reported adjusted earnings of $501 million or $0.97 (vs $0.89 forecast) per share for the period. - Revenue: $3.04 billion in Q4 vs. $2.83 billion in the same period last year. -Guidance: Next quarter EPS guidance: $0.72 to $0.74

    BAX is a safe heaven during this turmoil period. And the potential is relly good.
  • U
    US4All
    I believe next week BAX will surprise for the following Macroeconomic reasons:

    1. Renal business pickup due to increase in hospitalization activities in urgent care category
    2. Their consumable use in healthcare has gone up due to higher usage/disposal rate in healthcare
    3. Non-covid healthcare activity increase over the last 6 month
  • J
    Jim
    Waiting for two things to happen!

    1. Raise dividend...didn't happen
    2. CEO resign....soon hopefully!
  • J
    Jim
    Well, tomorrow is the big day...fingers crossed.
  • J
    John Blanton
    Will be 85 within the week, cnbc said great company and best management in the business.
  • j
    j
    Why is Bax stock price keeps going down in spite of good fundamentals and very good potential post-covid with its products and services?
  • J
    Jim
    Boy, no buyers just sellers of late.
    Truly sad what bad management can do.
  • J
    Jim
    Just curious if anyone panicked and baled on BAX the last few weeks?
  • C
    Cat
    Tomorrow BAX will be easily 85-90 $ / share. Mostly owned by institutions + SEC forbidden short selling. It will have very good results (see presentation of 2 march on their site - revenue is up by 5% plus SnP will gain back 3%.
  • J
    Jim
    Sure glad they didn't have a bad report!
  • J
    Jim
    wow...they completed that fast.
  • D
    DH
    As an insider, Joe needs to step down immediately! He has created a very toxic environment. Employees are extremely unhappy and not motivated. Anytime someone has an opportunity to leave, they are flying out the door. Baxter is not retaining good talent, and this is reflecting on the business and will continue to have long lasting effects.
  • T
    Thomas44
    Accounting issue may resolve in Baxter's favor....
  • S
    Sandy
    Great balance sheet with strong fundamentals, poised to rally to at least $120+ before end of 2020.